Saffron- Sport Trials – Ziggy Ardor

This store requires javascript to be enabled for some features to work correctly.

NEW! Unique & Rare
Plants & Trees available NOW

Saffron- Sport Trials

Saffron- Sport Trials

Below is a sample of some trials that have been done on:

  • VO2 Max
  • Anxiety
  • DOMS (Delyaed Onset Muscle Soreness)

 



Saffron Trials

Saffron for Improving VO₂ Max

Study Title: Potential Ergogenic Effects of Saffron
Summary:
Crocus sativus (saffron) is rich in carotenoids and has various health benefits. This study investigated its potential ergogenic (performance-enhancing) effects on muscular strength, pulmonary function, and reaction time.

Participants:

  • 28 nonactive, healthy male university students
  • Randomly assigned to saffron (n = 14) and control (n = 15) groups

Dosage & Duration:

  • Saffron group: 300 mg/day of dried saffron stigma for 10 days 
  • Control group: Placebo

Measurements:

  • Visual and audio reaction times
  • Maximum isometric and isotonic leg press forces
  • Assessed 1 day before and after supplementation

Findings:

  • Isometric force ↑ 10.1% (p < .0001; effect size = 0.432)
  • Isotonic force ↑ 6.1% (p < .0001; effect size = 0.662)
  • Visual reaction time improved (p < .05; EF = 0.217)
  • Audio reaction time improved (p < .05; EF = 0.214)

Conclusion:
Saffron may enhance muscle mitochondrial biogenesis, improve motor cortex function (leading to faster reaction times), improve blood perfusion in muscles, and facilitate oxygen transport.

Study link – PubMed



Saffron for DOMS (Delayed Onset Muscle Soreness)

Study Title: Preventive effects of 10-day supplementation with saffron and indomethacin on delayed-onset muscle soreness

Objective:
To evaluate the preventive effects of saffron and indomethacin on the biochemical and functional indicators of DOMS after a single eccentric exercise session.

Design:

  • 10-day randomized, double-blind, placebo-controlled, pretest-posttest
  • Conducted in a controlled research laboratory

Participants:
39 nonactive male university students
Divided into 3 groups:

  1. Saffron (n = 12)
  2. Indomethacin (n = 12)
  3. Control (n = 15)

Interventions:

  • Saffron group: 300 mg/day dried saffron powder
  • Indomethacin group: 75 mg/day (25 mg x 3/day)
  • Control: Placebo
  • Duration: 1 week before and 3 days after eccentric exercise

Measurements:

Taken at baseline, and at 24, 48, and 72 hours post-exercise
Included:

 

  1. Isometric and isotonic force
  2. Plasma CK and LDH
  3. Perceived pain
  4. Knee ROM
  5. Thigh circumference

 

  • Exercise protocol: 4 sets of 20 reps at 80% max isotonic force, 3 min rest

Results:

  • Saffron group had significantly decreased CK and LDH (P < 0.0001)
  • No decline in muscle force post-exercise in saffron group
  • Control group showed significant decline in isometric force (P < 0.0001)
  • No pain reported in saffron group
  • Indomethacin group experienced pain before 72 hours (P < 0.001)

Conclusion:
Saffron shows strong preventive effects on DOMS and may help alleviate its symptoms.

Study link – PubMed



Saffron for Anxiety

Study Title: Saffron in the treatment of depression, anxiety and other mental disorders: Current evidence and potential mechanisms of action

Background:
Depression and anxiety are common and costly mental health conditions. Current treatments (e.g., antidepressants, psychotherapy) come with side effects and limited efficacy. There’s a need for alternative options with fewer side effects and better outcomes.

Methods:
Non-systematic review of available in vitro, in vivo, and clinical evidence on saffron's efficacy, safety, and mechanisms of action for mental health.

Results:

  • Clinical trials show saffron and its constituents possess antidepressant and anti-anxiety properties
  • Effects are comparable to standard medications (e.g., fluoxetine, imipramine, citalopram)
  • Fewer reported side effects than pharmaceutical alternatives

Conclusion:
Saffron may be a safe and effective natural option for managing depression and anxiety.

Study link – PubMed